BioSpace News Archive

NCIB introduced by Knight proposes to buy back shares from shareholders at a 25% discount compared to last capital raise in 2016 of $10 per share

Centivo, a new type of self-funded health plan administrator, announced the addition of Gillian Printon as Head of National Accounts.

Recent rise in measles cases highlights the need for immunization

The Association of Community Cancer Centers (ACCC) in collaboration with AstraZeneca, Merck, and partner organizations the Association for Molecular Pathology (AMP), the National Society of Genetic Counselors (NSGC), and the Society of Gynecologic Oncology (SGO), has launched the Barriers to Quality Care in Ovarian Cancer project.

Partnership will allow clients to see treatment results in an immediate 360-degree viewpoint

Relationship strengthens the practice’s ability to remain independent, providing vast resources to enhance patient care and financial stability

Trading in WYG shares on the London Stock Exchange has been suspended and the outstanding shares of WYG are now owned by Tetra Tech.

If Yvonne and Claudio Yanes, the parents of Alonzo Yanes, could say one thing to the New York City Department of Education it would be this: There is nothing more important than the safety of our children.

Greenphire, the global leader in financial software for clinical trials, announced today that it has been selected by Atlantic Research Group (ARG), a rare and neurodegenerative disease, oncology and immunology-focused contract research organization (CRO) to implement its ClinCard and ConneX solutions to improve the clinical trial experience for sites and patients.

NeuroRx, Inc., a clinical stage biopharma company focused on development of drugs targeting depression and suicidality, announced today that it has initiated a pivotal Phase 2b/3 study for NRX-101 for the treatment of patients with Severe Bipolar Depression and Acute Suicidal Ideation and Behavior (ASIB)